Elos Medtech AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 231.5 million compared to SEK 187.2 million a year ago. Net income was SEK 21.9 million compared to SEK 17.6 million a year ago. Basic earnings per share from continuing operations was SEK 2.71 compared to SEK 2.18 a year ago.
For the nine months, sales was SEK 659.1 million compared to SEK 539.4 million a year ago. Net income was SEK 74.6 million compared to SEK 56 million a year ago. Basic earnings per share from continuing operations was SEK 9.24 compared to SEK 6.95 a year ago.